Related Experiment Videos
CD36 as a multiple-ligand signaling receptor in atherothrombosis
R Nergiz-Unal1, T Rademakers, J M E M Cosemans
1Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands.
Insights
CD36, a cell surface glycoprotein, interacts with ligands like oxidized lipoproteins to influence cellular responses. Understanding its signaling pathways offers potential therapeutic targets for atherothrombosis.
Area of Science:
- Cardiovascular Biology
- Molecular Cell Biology
- Immunology
Background:
- CD36 is a cell surface glycoprotein found on various cardiovascular cells, including platelets and monocytes.
- Its precise role in cellular function has been historically unclear despite its widespread expression.
Purpose of the Study:
- To review the known functions of CD36.
- To explore how CD36 mediates cellular responses through ligand interactions.
- To discuss the intracellular signaling pathways activated by CD36.
Main Methods:
- Literature review of studies on CD36 function and signaling.
- Analysis of CD36 interactions with ligands such as thrombospondin-1, oxidized lipoproteins, and fatty acids.
- Examination of CD36's role in intracellular signaling pathways like Src-family kinases, MAP kinases, NFκB, and Rho.
Main Results:
- CD36 binds to multiple ligands, influencing cellular behavior.
- Its transmembrane structure facilitates intracellular signaling, potentially with co-receptors.
- Evidence links CD36 to the activation of Src-family kinases, MAP kinases, NFκB, and Rho pathways.
Conclusions:
- CD36 plays a significant role in cellular responses within the cardiovascular system.
- Its involvement in key signaling cascades highlights its functional importance.
- CD36 presents a promising therapeutic target for modulating platelet and monocyte/macrophage activity to combat atherothrombosis.
Abstract:
The glycoprotein CD36, also known as glycoprotein IIIb/IV or FAT, is expressed on the surface of platelets, monocytes, microvascular endothelial cell, smooth muscle cells, cardiomyocytes and other cells of the cardiovascular system. In spite of its abundant presence, CD36 has remained for long a mysterious protein with a poorly understood role. In this paper, we review how CD36 can affect cellular responses by interaction with a variety of ligands, in particular thrombospondin-1, oxidized lipoproteins and fatty acids. Furthermore, given the structure of CD36 with two transmembrane domains and short cytoplasmic tails, we consider how this receptor can induce intracellular signaling, likely in junction with other cellular receptors or associated proteins in the membrane. Current literature points to activation of Src-family and mitogen-activated protein kinases, as well as to activation of the NFκB and Rho pathways. The new insights make CD36 attractive as a therapeutic target to suppress platelet and monocyte/macrophage function and thereby atherothrombosis.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
The JAK-STAT Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...